CN102988274A - 用于治疗肿瘤的药物缓释血管栓塞凝胶剂及其制备方法 - Google Patents
用于治疗肿瘤的药物缓释血管栓塞凝胶剂及其制备方法 Download PDFInfo
- Publication number
- CN102988274A CN102988274A CN2011100880563A CN201110088056A CN102988274A CN 102988274 A CN102988274 A CN 102988274A CN 2011100880563 A CN2011100880563 A CN 2011100880563A CN 201110088056 A CN201110088056 A CN 201110088056A CN 102988274 A CN102988274 A CN 102988274A
- Authority
- CN
- China
- Prior art keywords
- gel
- medicine
- temperature
- blood vessel
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (10)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110088056.3A CN102988274B (zh) | 2010-09-08 | 2011-04-08 | 用于治疗肿瘤的药物缓释血管栓塞凝胶剂及其制备方法 |
JP2013527446A JP2013540723A (ja) | 2010-09-08 | 2011-09-06 | 腫瘍治療のための医薬品徐放血管塞栓ゲル化剤及びその調製方法 |
PCT/CN2011/001510 WO2012031457A1 (zh) | 2010-09-08 | 2011-09-06 | 用于治疗肿瘤的药物缓释血管栓塞凝胶剂及其制备方法 |
US13/791,629 US20130195988A1 (en) | 2010-09-08 | 2013-03-08 | Vascular embolization gelling agent for sustained release of drugs for treating tumors and method for preparing the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010275424.0 | 2010-09-08 | ||
CN201010275424 | 2010-09-08 | ||
CN201110088056.3A CN102988274B (zh) | 2010-09-08 | 2011-04-08 | 用于治疗肿瘤的药物缓释血管栓塞凝胶剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102988274A true CN102988274A (zh) | 2013-03-27 |
CN102988274B CN102988274B (zh) | 2015-01-28 |
Family
ID=45810090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110088056.3A Active CN102988274B (zh) | 2010-09-08 | 2011-04-08 | 用于治疗肿瘤的药物缓释血管栓塞凝胶剂及其制备方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20130195988A1 (zh) |
JP (1) | JP2013540723A (zh) |
CN (1) | CN102988274B (zh) |
WO (1) | WO2012031457A1 (zh) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103333351A (zh) * | 2013-05-02 | 2013-10-02 | 杭州协合医疗用品有限公司 | 一种以透明质酸钠为原料制备可用作栓塞剂的交联透明质酸钠微球的工艺 |
CN103432632A (zh) * | 2013-09-16 | 2013-12-11 | 姚静 | 一种温度敏感凝胶组合物及制备方法 |
CN103536972A (zh) * | 2013-07-05 | 2014-01-29 | 北京大学 | 磁共振成像可检测的液体栓塞组合物及其制备和应用 |
CN103566413A (zh) * | 2013-10-29 | 2014-02-12 | 王鹏飞 | 一种温敏凝胶组合物及其应用 |
CN104095804A (zh) * | 2013-04-09 | 2014-10-15 | 中国医学科学院药物研究所 | 一种具有生物粘附性的原位胶膜剂及其制备方法 |
CN107281502A (zh) * | 2016-04-05 | 2017-10-24 | 上海市肿瘤研究所 | 一种复合显影温敏凝胶栓塞剂、制备方法及其应用 |
CN108434511A (zh) * | 2018-06-05 | 2018-08-24 | 李建辉 | 一种新型载化疗药的可降解止血材料及其制备方法 |
CN109195584A (zh) * | 2015-09-16 | 2019-01-11 | 国家科学研究中心 | 用于治疗恶性肿瘤和/或防止肿瘤复发的胶凝组合物 |
CN109224136A (zh) * | 2018-09-18 | 2019-01-18 | 苏州大学 | 一种涂层型硫酸钡纳米粒,制备方法及其用途 |
CN109289095A (zh) * | 2018-11-23 | 2019-02-01 | 淮海工学院 | 一种含盐酸利多卡因的肠镜凝胶剂及其制备方法 |
CN110215542A (zh) * | 2018-03-02 | 2019-09-10 | 成都远睿生物技术有限公司 | 一种形成血管临时阻塞物的方法 |
CN110575534A (zh) * | 2019-10-18 | 2019-12-17 | 南通大学 | 一种恩度合成药物及其制备方法与应用 |
CN110711007A (zh) * | 2019-10-28 | 2020-01-21 | 北京大学第一医院 | 一种经血管腔内保护性栓塞剂的注射装置 |
CN110819161A (zh) * | 2019-11-18 | 2020-02-21 | 南京森工生物科技有限公司 | 一种可印刷显影油墨及其制备方法 |
CN111249520A (zh) * | 2020-01-17 | 2020-06-09 | 中山大学孙逸仙纪念医院 | 一种装载小干扰rna纳米粒的复合水凝胶敷料及其制备方法 |
CN111432800A (zh) * | 2017-11-16 | 2020-07-17 | 佩尔西卡制药有限公司 | 利奈唑胺制剂 |
CN111632189A (zh) * | 2020-05-27 | 2020-09-08 | 深圳先进技术研究院 | 基于海洋源明胶的可注射水凝胶止血剂及应用和应用方法 |
CN111921003A (zh) * | 2020-09-04 | 2020-11-13 | 东南大学 | 一种磁响应热疗可控降解栓塞微球及其制备方法与应用 |
CN112438944A (zh) * | 2019-09-03 | 2021-03-05 | 苏州百迈生物医药有限公司 | 一种治疗肿瘤的温敏型凝胶药物组合物 |
WO2021042777A1 (zh) * | 2019-09-03 | 2021-03-11 | 苏州百迈生物医药有限公司 | 一种治疗肿瘤的多组分凝胶缓释药物组合物 |
CN112961285A (zh) * | 2021-02-09 | 2021-06-15 | 上海玮沐医疗科技有限公司 | 一种pvp栓塞微球及其制备方法 |
CN114272430A (zh) * | 2022-01-24 | 2022-04-05 | 科睿驰(深圳)医疗科技发展有限公司 | 一种温敏性栓塞微球及其制备方法 |
WO2022205986A1 (zh) * | 2021-04-02 | 2022-10-06 | 南昌大学 | 一种司维拉姆的新用途 |
CN115845117A (zh) * | 2022-11-21 | 2023-03-28 | 赛克赛斯生物科技股份有限公司 | 一种栓塞剂 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201402113A (zh) * | 2012-07-06 | 2014-01-16 | Xu-Ming Lai | 靛玉紅顆粒及其製備方法 |
US20140194370A1 (en) | 2013-01-08 | 2014-07-10 | University Of Utah Research Foundation | Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer |
KR101667328B1 (ko) * | 2015-05-07 | 2016-10-18 | 주식회사 엔게인 | 수화겔 입자 및 복합 색전물질 |
US20160346221A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
AU2016204933B2 (en) * | 2015-07-14 | 2020-02-27 | Best Pet Rx Ip, Inc. | Poloxamer-based intralesional injections for the delivery of chemotherapeutic agents |
CN105520906B (zh) * | 2015-12-24 | 2018-12-04 | 中国药科大学 | 一种载有盐酸阿霉素的温敏自愈水凝胶及其制备方法 |
CN106994121B (zh) * | 2016-01-26 | 2021-07-02 | 江苏恒瑞医药股份有限公司 | 一种用于治疗癌症的药物组合物 |
US11337994B2 (en) | 2016-09-15 | 2022-05-24 | University Of Utah Research Foundation | In situ gelling compositions for the treatment or prevention of inflammation and tissue damage |
US10849914B2 (en) | 2017-06-12 | 2020-12-01 | University Of Utah Research Foundation | Methods for producing chemoembolic agents for the delivery of anti-cancer agents |
CN107596108B (zh) * | 2017-10-14 | 2020-07-31 | 河南中医药大学 | 一种治疗小儿下消化道出血的肚脐贴 |
US20220023218A1 (en) * | 2018-11-30 | 2022-01-27 | Nextbiomedical Co., Ltd. | Hydration gel particle for chemoembolization comprising biodegradable polymer |
RU2762238C1 (ru) * | 2021-02-17 | 2021-12-16 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации | Способ комбинированного лечения местно-распространенных злокачественных новообразований носоглотки |
WO2023044491A1 (en) * | 2021-09-17 | 2023-03-23 | Northwestern University | Lipiodol formulation for transarterial chemoimmunoembolization |
CN114748674A (zh) * | 2022-04-18 | 2022-07-15 | 上海方润介入器械有限公司 | 一种预载药物的栓塞微球及加工方法 |
CN116196461B (zh) * | 2023-03-08 | 2024-05-24 | 华中科技大学 | 一种长效超声显影性温敏纳米凝胶介入栓塞材料的制备方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273860A (zh) * | 2000-05-12 | 2000-11-22 | 苏州医学院附属第一医院 | 一种血管栓塞剂及其制备工艺 |
CN1586624A (zh) * | 2004-06-30 | 2005-03-02 | 中国人民解放军南京军区福州总医院 | 水溶性几丁糖介入栓塞化疗药缓释凝胶微球 |
CN1679620A (zh) * | 2005-01-25 | 2005-10-12 | 天津大学 | 可注射异丙基丙烯酰胺三元共聚物血栓材料制备及应用 |
CN101642560A (zh) * | 2009-08-24 | 2010-02-10 | 武汉大学 | 一种抗肿瘤药物组合物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06329542A (ja) * | 1993-05-21 | 1994-11-29 | Kibun Food Chemifa Co Ltd | 不溶性アルギン酸塩粒子を含む局所血管止血用組成物および動脈化学塞栓用組成物 |
JP3879018B2 (ja) * | 1996-07-19 | 2007-02-07 | アステラス製薬株式会社 | 生体適合性物質の水不溶化多孔性粒子及びその製造法 |
US6831770B2 (en) * | 2000-03-03 | 2004-12-14 | Sipix Imaging, Inc. | Electrophoretic display and novel process for its manufacture |
AU2002219935A1 (en) * | 2000-11-28 | 2002-06-11 | Focal, Inc. | Polyalkylene glycol viscosity-enhancing polymeric formulations |
US20020192289A1 (en) * | 2001-06-18 | 2002-12-19 | Ji Zheng | Polymer gel for cancer treatment |
JP2004175698A (ja) * | 2002-11-26 | 2004-06-24 | Toray Ind Inc | 塞栓粒子材料の製造方法 |
JP4909071B2 (ja) * | 2003-03-24 | 2012-04-04 | プルーローメッド, インコーポレイテッド | 逆感熱性ポリマーを使用する一時的な塞栓形成 |
AU2004268661A1 (en) * | 2003-09-02 | 2005-03-10 | Alza Corporation | Novel drug compositions and dosage forms of topiramate |
JP5217149B2 (ja) * | 2006-03-31 | 2013-06-19 | 東レ株式会社 | 生分解性球状粒子 |
JP2007325824A (ja) * | 2006-06-09 | 2007-12-20 | National Institute For Materials Science | 局所投与型化学療法用材料 |
KR100802010B1 (ko) * | 2006-06-30 | 2008-02-12 | 전북대학교산학협력단 | 테크네튬주석 나노콜로이드 및 그 제조방법 |
EP2173389A2 (en) * | 2007-06-25 | 2010-04-14 | Lipopeptide AB | New medical products |
EP2254651A4 (en) * | 2008-02-29 | 2013-03-06 | Pluromed Inc | LOCAL EMBOLIZATION USING THERMOSENSITIVE POLYMERS |
-
2011
- 2011-04-08 CN CN201110088056.3A patent/CN102988274B/zh active Active
- 2011-09-06 JP JP2013527446A patent/JP2013540723A/ja active Pending
- 2011-09-06 WO PCT/CN2011/001510 patent/WO2012031457A1/zh active Application Filing
-
2013
- 2013-03-08 US US13/791,629 patent/US20130195988A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273860A (zh) * | 2000-05-12 | 2000-11-22 | 苏州医学院附属第一医院 | 一种血管栓塞剂及其制备工艺 |
CN1586624A (zh) * | 2004-06-30 | 2005-03-02 | 中国人民解放军南京军区福州总医院 | 水溶性几丁糖介入栓塞化疗药缓释凝胶微球 |
CN1679620A (zh) * | 2005-01-25 | 2005-10-12 | 天津大学 | 可注射异丙基丙烯酰胺三元共聚物血栓材料制备及应用 |
CN101642560A (zh) * | 2009-08-24 | 2010-02-10 | 武汉大学 | 一种抗肿瘤药物组合物 |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104095804A (zh) * | 2013-04-09 | 2014-10-15 | 中国医学科学院药物研究所 | 一种具有生物粘附性的原位胶膜剂及其制备方法 |
CN103333351B (zh) * | 2013-05-02 | 2015-11-25 | 杭州协合医疗用品有限公司 | 一种以透明质酸钠为原料制备可用作栓塞剂的交联透明质酸钠微球的工艺 |
CN103333351A (zh) * | 2013-05-02 | 2013-10-02 | 杭州协合医疗用品有限公司 | 一种以透明质酸钠为原料制备可用作栓塞剂的交联透明质酸钠微球的工艺 |
CN103536972A (zh) * | 2013-07-05 | 2014-01-29 | 北京大学 | 磁共振成像可检测的液体栓塞组合物及其制备和应用 |
CN103432632A (zh) * | 2013-09-16 | 2013-12-11 | 姚静 | 一种温度敏感凝胶组合物及制备方法 |
CN103432632B (zh) * | 2013-09-16 | 2015-11-25 | 姚静 | 一种温度敏感凝胶组合物及制备方法 |
CN103566413A (zh) * | 2013-10-29 | 2014-02-12 | 王鹏飞 | 一种温敏凝胶组合物及其应用 |
CN103566413B (zh) * | 2013-10-29 | 2015-04-08 | 王鹏飞 | 一种温敏凝胶组合物及其应用 |
CN109195584A (zh) * | 2015-09-16 | 2019-01-11 | 国家科学研究中心 | 用于治疗恶性肿瘤和/或防止肿瘤复发的胶凝组合物 |
CN107281502A (zh) * | 2016-04-05 | 2017-10-24 | 上海市肿瘤研究所 | 一种复合显影温敏凝胶栓塞剂、制备方法及其应用 |
CN107281502B (zh) * | 2016-04-05 | 2021-05-04 | 上海市肿瘤研究所 | 一种复合显影温敏凝胶栓塞剂、制备方法及其应用 |
CN111432800B (zh) * | 2017-11-16 | 2023-12-15 | 佩尔西卡制药有限公司 | 利奈唑胺制剂 |
CN111432800A (zh) * | 2017-11-16 | 2020-07-17 | 佩尔西卡制药有限公司 | 利奈唑胺制剂 |
CN110215542A (zh) * | 2018-03-02 | 2019-09-10 | 成都远睿生物技术有限公司 | 一种形成血管临时阻塞物的方法 |
CN108434511A (zh) * | 2018-06-05 | 2018-08-24 | 李建辉 | 一种新型载化疗药的可降解止血材料及其制备方法 |
CN109224136A (zh) * | 2018-09-18 | 2019-01-18 | 苏州大学 | 一种涂层型硫酸钡纳米粒,制备方法及其用途 |
CN109289095A (zh) * | 2018-11-23 | 2019-02-01 | 淮海工学院 | 一种含盐酸利多卡因的肠镜凝胶剂及其制备方法 |
CN112516073A (zh) * | 2019-09-03 | 2021-03-19 | 苏州百迈生物医药有限公司 | 一种治疗肿瘤的多组分凝胶缓释药物组合物 |
CN112438944A (zh) * | 2019-09-03 | 2021-03-05 | 苏州百迈生物医药有限公司 | 一种治疗肿瘤的温敏型凝胶药物组合物 |
WO2021042777A1 (zh) * | 2019-09-03 | 2021-03-11 | 苏州百迈生物医药有限公司 | 一种治疗肿瘤的多组分凝胶缓释药物组合物 |
WO2021042778A1 (zh) * | 2019-09-03 | 2021-03-11 | 苏州百迈生物医药有限公司 | 一种治疗肿瘤的温敏型凝胶药物组合物 |
CN110575534A (zh) * | 2019-10-18 | 2019-12-17 | 南通大学 | 一种恩度合成药物及其制备方法与应用 |
CN110575534B (zh) * | 2019-10-18 | 2023-10-27 | 南通大学 | 一种恩度合成药物及其制备方法与应用 |
CN110711007A (zh) * | 2019-10-28 | 2020-01-21 | 北京大学第一医院 | 一种经血管腔内保护性栓塞剂的注射装置 |
CN110819161A (zh) * | 2019-11-18 | 2020-02-21 | 南京森工生物科技有限公司 | 一种可印刷显影油墨及其制备方法 |
CN111249520A (zh) * | 2020-01-17 | 2020-06-09 | 中山大学孙逸仙纪念医院 | 一种装载小干扰rna纳米粒的复合水凝胶敷料及其制备方法 |
CN111632189A (zh) * | 2020-05-27 | 2020-09-08 | 深圳先进技术研究院 | 基于海洋源明胶的可注射水凝胶止血剂及应用和应用方法 |
CN111921003A (zh) * | 2020-09-04 | 2020-11-13 | 东南大学 | 一种磁响应热疗可控降解栓塞微球及其制备方法与应用 |
CN112961285A (zh) * | 2021-02-09 | 2021-06-15 | 上海玮沐医疗科技有限公司 | 一种pvp栓塞微球及其制备方法 |
WO2022205986A1 (zh) * | 2021-04-02 | 2022-10-06 | 南昌大学 | 一种司维拉姆的新用途 |
CN114272430A (zh) * | 2022-01-24 | 2022-04-05 | 科睿驰(深圳)医疗科技发展有限公司 | 一种温敏性栓塞微球及其制备方法 |
CN115845117A (zh) * | 2022-11-21 | 2023-03-28 | 赛克赛斯生物科技股份有限公司 | 一种栓塞剂 |
CN115845117B (zh) * | 2022-11-21 | 2024-02-20 | 赛克赛斯生物科技股份有限公司 | 一种栓塞剂 |
Also Published As
Publication number | Publication date |
---|---|
JP2013540723A (ja) | 2013-11-07 |
US20130195988A1 (en) | 2013-08-01 |
WO2012031457A1 (zh) | 2012-03-15 |
CN102988274B (zh) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988274B (zh) | 用于治疗肿瘤的药物缓释血管栓塞凝胶剂及其制备方法 | |
JP5792729B2 (ja) | 移植可能な生体吸収性ポリマー | |
US6680046B1 (en) | Method of embolization using polyvinyl alcohol microspheres | |
CN102309458B (zh) | 海藻酸钠交联莫西沙星缓释微球、其制备方法和用途以及含有所述微球的血管靶向栓塞剂 | |
JP2002519364A (ja) | 乳酸エチルを含有する血管塞栓形成組成物及びその使用方法 | |
JP2008513381A (ja) | パクリタキセル−アルギン酸ナトリウムマイクロスフェア血管塞栓剤及びその製造方法 | |
KR20130010402A (ko) | 온도 및 피에이치 민감성 하이드로젤의 인터벤셔널 인젝션에 기반한 간암치료용 약물전달체 | |
US20200030238A1 (en) | Microspheres containing therapeutic agents and related methods of use | |
CN113018463A (zh) | 一种含放射性核素的医用天然高分子微球及其制备方法和用途 | |
CN107875436B (zh) | 一种负载碳酸氢钠粉末的液体栓塞剂组合物及其应用 | |
KR20150131435A (ko) | 제 1 및 제 2 생분해성 마이크로 비드를 포함하는 화학색전용 조성물 및 이의 제조방법 | |
CN104324032B (zh) | 抗结核药物三联复方微球血管靶向栓塞缓释剂及其制备方法和用途 | |
CN102670611B (zh) | 抗结核药物三联复方微球血管靶向栓塞缓释剂及其制备方法和用途 | |
CN101108262B (zh) | 一种肿瘤介入栓塞剂去甲斑蝥素-海藻酸钙/聚乳酸-乙醇酸共聚物控释微球 | |
CN115845117B (zh) | 一种栓塞剂 | |
CN1969823A (zh) | 一种含氟尿嘧啶及其增效剂的缓释剂 | |
CN1969824A (zh) | 一种含氟尿嘧啶及其增效剂的抗癌缓释剂 | |
Liu et al. | A Novel Coacervate Embolic Agent for Tumor Chemoembolization | |
CN100998558A (zh) | 一种同载卡莫司汀和氟尿嘧啶的抗癌缓释剂 | |
CN1875936B (zh) | 含克罗拉滨和细胞毒药物的抗癌缓释剂 | |
CN1957920B (zh) | 一种同载氟尿嘧啶及其增效剂的抗癌缓释剂 | |
CN1969826A (zh) | 一种载氟尿嘧啶及其增效剂的缓释剂 | |
CN101234087A (zh) | 一种含泊甙的抗癌缓释注射剂 | |
CN101637445A (zh) | 一种复方抗癌缓释剂 | |
CN101637446A (zh) | 一种含复方抗癌缓释剂的注射剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170918 Address after: 215500 Jiangsu city of Dongtai province high tech Park (head range town) weft four Road No. 1 Patentee after: JIANGSU BOCHAO NEW MATERIAL TECHNOLOGY CO., LTD. Address before: 200032 Shanghai city Xuhui District Xietu Road 2200 Lane 25 Patentee before: Shanghai Cancer Institute |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171010 Address after: 1 No. 215519 Jiangsu province Changshou City Hai Yu Zhen Sheng Yu Road Patentee after: Jiangsu Shen Shen Medical Technology Co., Ltd. Address before: 215500 Jiangsu city of Dongtai province high tech Park (head range town) weft four Road No. 1 Patentee before: JIANGSU BOCHAO NEW MATERIAL TECHNOLOGY CO., LTD. |